Galux
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets 2025-09-22 21:00
Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets 2025-03-17 21:00
1